Resistin, Visfatin, Adiponectin, and Leptin: Risk of Breast Cancer in Pre- and Postmenopausal Saudi Females and Their Possible Diagnostic and Predictive Implications as Novel Biomarkers
Table 3
Pearson’s correlation analysis using different variables between all groups and healthy control group.
Variables
BMI
WC
DBP
SBP
Gluc
TG
TC
LDLc
HDLc
Leptin
Adipo.
Resi.
All groups
BMI
1
WC
.142
1
DBP
.112
.073
1
SBP
-.068-
-.095-
.020
1
Gluco.
.035
.153
.077
.168*
1
TG
.132
.119
.105
.008
-.018-
1
TC
.029
-.008-
.026
.020
-.049-
.296**
1
LDLc
.256**
.114
.151
-.027-
.162*
.214**
.306**
1
HDLc
-.074-
.060
.001
-.105-
.074
-.109-
-.210-**
.004
1
Leptin
.313**
.276**
.187*
-.008-
.176*
.242**
-.052-
.182*
-.170-*
1
Adipo.
-.232-**
-.295-**
-.157-
.023
-.089-
-.377-**
-.094-
-.224-**
.216**
-.595-**
1
Resistin
.051
.051
.052
.192-*
.135-
.185*
.316**
.112
-.281-**
.092
-.123-
1
Visfatin
.228**
..259**
.043
.075
.182*
.283**
-.032-
.088
-.144-
.549**
.506-**
.136
Healthy control group
BMI
1
WC
-.224-
1
DBP
.152
-.278-*
1
SBP
-.174-
-.088-
.092
1
Gluco.
.022
.053
-.017-
-.017-
1
TG
-.062-
.106
.210
.063
.055
1
TC
-.129-
-.075-
.426**
-.038-
.034
.030
1
LDLc
.254*
-.043-
.076
.121
.079
.176
.120
1
HDLc
-.007-
.130
-.059-
-.035-
.315**
.108
.163
.197
1
Leptin
-.031-
.120
-.136-
.061
-.072-
-.077-
-.179-
-.003-
.137
1
Adipone.
-.038-
-.054-
.089
.176
-.115-
.043
-.147-
.065
-.008-
-.002-
1
Resistin
-.074-
-.076-
-.184-
.012
-.297-
-.220-
-.018-
-.196-
.014
-.215-
.122
1
Visfatin
-.126-
-.201-
-.019-
.015
.050
-.085-
-.014-
-.310-*
.085
-.016-
-.024-
-.008-
Adipo.: adiponectin; Gluco.: glucose. **Correlation is significant at the 0.01 level; *correlation is significant at the 0.05 level.
